These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 18388120)

  • 1. S-cystatin C formulae or combination of s-cystatin C and s-creatinine formulae do not improve prediction of GFR.
    Urbaniak J; Weyde W; Smolska D; Zagocka E; Klak R; Kusztal M; Krajewska M; Wozniak M; Klinger M
    Nephrol Dial Transplant; 2008 Jul; 23(7):2425-6; author reply 2426-7. PubMed ID: 18388120
    [No Abstract]   [Full Text] [Related]  

  • 2. A Comparison of GFR estimating formulae based upon s-cystatin C and s-creatinine and a combination of the two.
    Tidman M; Sjöström P; Jones I
    Nephrol Dial Transplant; 2008 Jan; 23(1):154-60. PubMed ID: 17911090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma cystatin C for estimating residual GFR (rGFR) in dialysis patients.
    Tidman M; Sjöström P; Jones I
    Nephrol Dial Transplant; 2008 Mar; 23(3):1072-3; author reply 1073. PubMed ID: 17984103
    [No Abstract]   [Full Text] [Related]  

  • 4. Cystatin C-based equations in renal transplantation: moving toward a better glomerular filtration rate prediction?
    Maillard N; Mariat C; Bonneau C; Mehdi M; Thibaudin L; Laporte S; Alamartine E; Chamson A; Berthoux F
    Transplantation; 2008 Jun; 85(12):1855-8. PubMed ID: 18580481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding estimated glomerular filtration rate: implications for identifying chronic kidney disease.
    Rule AD
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):242-9. PubMed ID: 17420668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of cystatin C and serum creatinine in the estimative of glomerular filtration rate in children.
    Cordeiro VF; Pinheiro DC; Silva GB; Lima JW; Mota RM; Libório AB; Daher EF
    Clin Chim Acta; 2008 May; 391(1-2):46-50. PubMed ID: 18298952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a new plasma cystatin C-based formula and the Modification of Diet in Renal Disease creatinine-based formula for determination of glomerular filtration rate.
    Sterner G; Björk J; Carlson J; Grubb A; Nyman U
    Scand J Urol Nephrol; 2009; 43(3):242-9. PubMed ID: 19291590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comment on 'Comparison between creatinine and cystatin C-based GFR equations in renal transplantation'.
    Zitta S; Holzer H; Reibnegger G; Estelberger W
    Nephrol Dial Transplant; 2008 May; 23(5):1764; author reply 1765. PubMed ID: 18204092
    [No Abstract]   [Full Text] [Related]  

  • 9. Cystatin C could be a replacement to serum creatinine for diagnosing and monitoring kidney function in children.
    Narvaez-Sanchez R; Gonzalez L; Salamanca A; Silva M; Rios D; Arevalo S; Gastelbondo R; Sanchez J
    Clin Biochem; 2008 May; 41(7-8):498-503. PubMed ID: 18280806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can cystatin C replace creatinine to estimate glomerular filtration rate? A literature review.
    Zahran A; El-Husseini A; Shoker A
    Am J Nephrol; 2007; 27(2):197-205. PubMed ID: 17361076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum cystatin C as an endogenous marker of renal function in patients with chronic kidney disease.
    Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
    Ren Fail; 2008; 30(2):181-6. PubMed ID: 18300118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the glomerular filtration rate calculated by two creatinine-based and three cystatin-C-based formulae in hospitalized elderly patients.
    Ramel A; Jonsson PV; Bjornsson S; Thorsdottir I
    Nephron Clin Pract; 2008; 108(1):c16-22. PubMed ID: 18075276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient selection has a strong impact on cystatin C and Modification of Diet in Renal Disease (MDRD) estimated glomerular filtration rate.
    Larsson A; Flodin M; Hansson LO; Carlsson L
    Clin Biochem; 2008 Nov; 41(16-17):1355-61. PubMed ID: 18674527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of the kidney function in patients with rheumatoid arthritis: plasma cystatin C versus 51Cr-EDTA clearance.
    Karstila K; Harmoinen AP; Lehtimäki TJ; Korpela MM; Mustonen JT; Saha HH
    Nephron Clin Pract; 2008; 108(4):c284-90. PubMed ID: 18434750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can serial measurements of cystatin C accurately detect early renal function decline?
    Herget-Rosenthal S
    Nat Clin Pract Nephrol; 2005 Dec; 1(2):68-9. PubMed ID: 16932367
    [No Abstract]   [Full Text] [Related]  

  • 16. Need of standardization for creatinine and cystatin C-based GFR equations in renal transplantation.
    Pöge U; Gerhardt TM; Stoffel-Wagner B; Woitas RP
    Nephrol Dial Transplant; 2008 May; 23(5):1763; author reply 1763-4. PubMed ID: 18283089
    [No Abstract]   [Full Text] [Related]  

  • 17. Cystatin C as a marker of early changes of renal function in Fabry nephropathy.
    Feriozzi S; Germain DP; Di Vito R; Legrand A; Ricci R; Barbey F
    J Nephrol; 2007; 20(4):437-43. PubMed ID: 17879210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of cystatin C-based glomerular filtration rate estimation formulae in chronic kidney disease].
    Li XL; Liang M; Yang XB
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):575-8. PubMed ID: 20335143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The usefulness of plasma cystatin C determination as a marker of glomerular filtration rate].
    Symonides B; Wieteska M; Bobilewicz D
    Przegl Lek; 2007; 64(1):54-8. PubMed ID: 18183833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Derivation and validation of cystatin C-based prediction equations for GFR in children.
    Zappitelli M; Parvex P; Joseph L; Paradis G; Grey V; Lau S; Bell L
    Am J Kidney Dis; 2006 Aug; 48(2):221-30. PubMed ID: 16860187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.